Remdesivir for patients hospitalised with COVID-19 (adults and children aged 12 years and older)

For hospital prescribers. Defines routine access to remdesivir and criteria for a shortage

I am interested in
Select a topic
Anticipatory Prescribing – NICE Evidence
3rd May 2018

A link to the evidence for the benefits of anticipatory prescribing

End of Life Care for All (e-ELCA) – non-clinical
20th July 2016

End of Life Care for All (e-ELCA) is an e-learning resource designed to enhance the training and education of all those involved in delivering end of life care. The e-learning sessions available on this site are suitable for social care workers, administrative and clerical staff and volunteers.

The website is not designed to give medical advice, but rather to give information on a wide range of topics to health and social care staff, no matter where they work. Find out more